Antibiotic-Free RNA-OUT Marker for Mammalian Expression and DNA Vaccine Vectors

NTC PRODUCTS AND SERVICES


VECTORS
X
Mammalian Vectors
XAntibiotic-Free Vecotrs
XRig-I Activating Vectors
XpDNAVACCUltra Vector
XLinear Vectors
XRecombineering Vectors
XAutolytic E. coli Cell Lines
XGene Sllencing (transient)
XGene Sllencing (retroviral, stable)
XAnti-Silencing Elements

CELL LINES
XAutolytic E. coli Cell Lines

DNA VACCINES
XXX
DNA Vaccine References
XXX
Pricing
XXXX
PRECISION CLONING
XX
Services and Pricing

RECOMBINANT PROTEINS
X
pVEX™
X
Fluorescent Proteins

PLASMIDS
XSmall Scale Plasmid DNA
XSmall Scale C of A
XLarge Scale Plasmid DNA
XLarge Scale C of A
XPlasmid DNA Order Form
XE. coli Cell paste
XPlasmid Detox Service, NEW!
X
DNA FERMENTATION PROCESS
X
HyperGRO™ Process
X
HyperGRO™ Licensing
X
HyperGRO™ Pricing

PROCESS DEVELOPMENT
X
Process Development Basics
X
Process Licensing

HYPERTAQ™ DNA POLYMERASE


NTC Contacts:

Email: support@natx.com
Phone: (402) 472-6530
Fax: (402) 472-6532

site map | home | contact us


XXVersions


NTC offers two of it's popular mammalian expression and immunization vectors (equivalent to NTC7482 and NTC7485), now in the antibiotic-free format:

• NTC8485-eRNA41H-EGFP: Native (no tag), reporter for use as a control, or removed in order to clone a new gene, with antibiotic-free RNA-OUT selection on sucrose. (Manual)
• NTC8482-eRNA41H: secreted (TPA tag), empty, ready for cloning a new gene of interest. (Manual)

XXDescription

Antibiotic resistance markers, typically kanamycin resistance (KanR), allow selective retention of plasmid DNA during bacterial fermentation and are the most commonly utilized selectable markers. To ensure safety, however, regulatory agencies recommend elimination of antibiotic-resistance markers from therapeutic and vaccine plasmid DNA vectors. The presence of an antibiotic resistance gene in the plasmid backbone is considered undesirable by regulatory agencies, due to the potential transfer of antibiotic resistance to endogenous microbial flora and the potential activation and transcription of the genes from mammalian promoters after cellular incorporation into the genome.

Now, NTC has designed an antibiotic-free selection system (Fig. 1). The KanR gene has been replaced with a 150bp RNA-OUT antisense RNA, which represses expression of a counter selectable marker (SacB) from the host chromosome.

Fig. 1: RNA-OUT selectable marker

 DNA Vaccine Vecotr, Antibiotic freeRNA-OUT selectable marker

In addition, NTC offers a retrofitting service, directly replacing the Kan gene in your current vectors with the RNA-OUT cassette.

XXFeatures:


• Replaces KanR resistance gene with antisense RNA-OUT, 150bp RNA marker
• Kit includes strain for selection with RNA-OUT
• Enhanced expression with optimized, chimeric promoter-intron (SV40-CMV-HTLV-1 R-U5-synthetic intron)
• Complies with regulatory guidance
• Increased vaccine potency and safety by replacement of KanR gene
• Improved DNA backbone for maximum plasmid production in E. coli (>2.5g/L)

XXVector Specifications:


NTC8485-EGFP.  Marker is removed to clone a gene of interest.

DNA Vaccine Vector, NTC8485-EGFP.  Marker is removed to clone a gene of interest.

Vector Features: trpA prokaryotic terminator: 3739-28; Primosomal assembly site (PAS-BH) extended origin: 32-316; pUC replication origin: 317-1331; Sucrose selection marker (RNA-OUT): 1348-1492; SV40 enhancer: 1493-1719; CMV enhancer: 1726-2283; CMV promoter: 2284-2403; Untranslated leader (exon 1): 2404-2590; HTLV-1 R-U5: 2475-2700; Synthetic Rabbit β-globin-based 3’ intron: 2709-2815; Intron: 2591-2815; Exon 2 (SR-protein binding sites-Kozak):2816-2864; EGFP: 2865-3584; SalI-BglII cloning cassette: 2859-3594; Eukaryotic terminator: 3595-3729. 

Contact NTC, Toll free: 1-(888) WIZ-BANG

Plasmids, Recombinant Proteins, DNA Vaccines, Viral Vectors, Therapeutic Genes, Fermentation Technology for Gene Therapy and Biotechnology
NTC's free resource "Site" for the biotechnology industry,
including Databases and Sequences Analysis Tool
s



WWW http://www.natx.com